GL261 is a well-characterized model displaying multiple features of GBM, including high inflammation, angiogenesis, high levels of major histocompatibility complex class, high CXCR4/CXCL12 and Ras expression, and p53 tumor suppressor gene point mutations [16]. The gene discussed is CXCL12; the disease is glioblastoma.